| Scientific Name |
Dasatinib
|
|---|---|
| Brand Name |
Sprycel
|
| Risk |
Risk of (PAH) Pulmonary Arterial Hypertension. The association of BCR-ABL targeting Tyrosine Kinase inhibitors (TKIs) including SPRYCEL® (dasatinib) with the risk of hepatitis B virus reactivation .
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|